Back to 13F data
Q1 2026
UNITED THERAPEUTICS CORP DEL
Original CUSIPs: 91307C102. This page shows current managers, quarterly changes, and primary SEC sources.
Current managers
1
Combined value
$65.9M
Current managers
1
Calculated from each manager’s latest available 13F.
Total shares
111,169
Aggregated at company level with original CUSIP details preserved.
Combined value
$65.9M
Market values are added across managers reporting the same quarter.
Themes
Healthcare
Local mappings are used only for search and classification.
Four-quarter trend
Four-quarter ownership trend
Manager actions by quarter
Current tracked managers holding this company
| Manager | Quarter | Market value | Shares | Portfolio weight | Current-quarter change | Share change | Value change | SEC source |
|---|---|---|---|---|---|---|---|---|
| Bridgewater Associates Ray Dalio / Bridgewater | Q1 2026 | $65,920,994 | 111,169 | 0.29% | Increased +72.10% | +46,574 | +$34,447,080 | XML 05/15/2026 |
Original CUSIP details
| Manager | Issuer | CUSIP | Security class | Market value | Shares | Weight | Source |
|---|---|---|---|---|---|---|---|
| Bridgewater Associates | UNITED THERAPEUTICS CORP DEL | 91307C102 | COM | $65,920,994 | 111,169 | 0.29% | SEC XML |
Quarterly holdings details
| Quarter | Current managers | Combined value | Total shares | Manager details |
|---|---|---|---|---|
| Q2 2025 | 1 | $56,067,157 | 195,118 | Bridgewater Associates New position |
| Q3 2025 | 1 | $6,734,609 | 16,065 | Bridgewater Associates Reduced |
| Q4 2025 | 1 | $31,473,914 | 64,595 | Bridgewater Associates Increased |
| Q1 2026 | 1 | $65,920,994 | 111,169 | Bridgewater Associates Increased |
Data source
Holdings facts come from SEC 13F information tables. Tickers, company aliases, and themes are used only for search and normalized display, not as a holdings source.